Remove views-analysis
article thumbnail

Deep Dive: Patients and Partnerships 2022

pharmaphorum

The concept of patient centricity has been a key talking point across the healthcare ecosystem for years. Having recognised the tangible benefits that their unique insights and experiences can bring to the table, decision-makers are increasingly seeking new opportunities to partner with patients across a product’s lifecycle.

article thumbnail

Real Chemistry and WhizAI Announce Partnership to Develop a Generative AI-Based Patient Journey Visualization and Analytics Solution

PM360

Real Chemistry , a leading provider of AI-driven insights and marketing and communications for the healthcare industry, is partnering with WhizAI , a generative AI-powered analytics platform purpose-built for life sciences and healthcare, to develop a patient journey visualization and analytics solution. The work we do at IPM.ai

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How eligible patient numbers affect price of rare disease drugs in France

pharmaphorum

The HTA body, the CT ( Commission de la Transparence – Transparency Commission), is charged with providing guidance to inform pricing negotiations in two main forms: a comparative clinical benefit rating, the ASMR ( Amélioration du Service Médical Rendu ), and a target patient population. Relationship between ATC and eligible patient number.

article thumbnail

The futility of banner ads

World of DTC Marketing

The vast majority of digital advertising is not being viewed at all, yet the drug industry continues to waste money on them. Research has shown that only 35% of digital display ads received views. Display is an incredibly low-effort way to spend your marketing budget, whether trying to reach physicians or patients.

article thumbnail

Steps to building a more patient-centric industry

pharmaphorum

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.

Patients 105
article thumbnail

Patient centricity and the changing pharmaceutical vista

pharmaphorum

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

article thumbnail

Transforming the Patient Experience: Leveraging Cloud Monitoring for Seamless Healthcare Service

Impetus Digital

Cloud technology in healthcare has become critical in improving patient care and revolutionizing healthcare systems. Patients are more willing than ever to seek out greater healthcare services if their expectations are not met. The Patient Experience: What Is It, and Why Is It Important? So what exactly is it?